Recommendations Tracker
HHS-OIG provides independent and objective oversight that promotes economy, efficiency, and effectiveness in HHS programs and operations. To drive this positive change, we produce reports and identify recommendations for improvement. We have developed this public-facing page for tracking all of our open recommendations.
Use the Top Unimplemented View below to read OIG's Top Unimplemented Recommendations. In OIG’s view, these top recommendations for HHS programs, if implemented, would have the greatest impact in terms of cost savings, program effectiveness and efficiency, and public health and safety. Learn more
Summary of All Recommendations
Updated Monthly · Last updated on April 15, 2026
1,094
Unimplemented
recommendations
3,367
Implemented and Closed
recommendations since FY 2017
Views
OIG Recommendations Grouped by Report
-
Noridian Healthcare Solutions Reopened and Corrected Cost Report Final Settlements To Collect $11 Million in Net Overpayments That Had Been Made to Medicare Providers
24-A-06-010.01We recommend that Noridian Healthcare Solutions develop and deliver additional education to auditors and audit supervisors regarding applicable criteria and review requirements.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 02/05/2024
- Legislative Related
- No
24-A-06-010.02We recommend that Noridian Healthcare Solutions develop and implement procedures to allow enough time for adequate auditor and supervisory review of audit adjustments and related actions.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 02/05/2024
- Legislative Related
- No
24-A-06-010.03We recommend that Noridian Healthcare Solutions develop and implement enhanced procedures so that supervisors and higher-level reviewers are better qualified to detect incorrect audit adjustments.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 02/05/2024
- Legislative Related
- No
-
HHS's Oversight of Automatic Provider Relief Fund Payments Was Generally Effective but Improvements Could Be Made
24-A-02-011.01We recommend that the Health Resources and Services Administration perform postpayment reviews of 108 renal dialysis providers that attested to and kept automatic PRF payments totaling $58 million and recoup any outstanding overpayments from these providers.- Status
- Closed Implemented
- Responsible Agency
- HRSA
- Response
- Concur
- Potential Savings
- $57,506,123
- Last Update Received
- -
- Closed Date
- 05/22/2024
- Legislative Related
- No
24-A-02-011.02We recommend that the Health Resources and Services Administration perform postpayment reviews of 58 providers with multiple subsidiary organizations that attested to and kept automatic PRF payments totaling $130 million and recoup any outstanding overpayments from these providers.- Status
- Open Unimplemented
- Responsible Agency
- HRSA
- Response
- Concur
- Potential Savings
- $130,044,256
- Last Update Received
- 03/18/2026
- Next Update Expected
- 09/20/2026
- Legislative Related
- No
24-A-02-011.03We recommend that the Health Resources and Services Administration perform postpayment reviews of 642 providers that attested to and kept $165 million in automatic PRF payments for which they were not eligible and recoup any outstanding overpayments from these providers.- Status
- Open Unimplemented
- Responsible Agency
- HRSA
- Response
- Concur
- Potential Savings
- $164,642,600
- Last Update Received
- 03/18/2026
- Next Update Expected
- 09/20/2026
- Legislative Related
- No
24-A-02-011.04We recommend that the Health Resources and Services Administration commit to strengthening its procedures that may apply to future programs of a similar nature to better ensure that; providers receive their intended share of financial assistance; financial assistance payments are properly calculated; data and data sources are appropriate, current, complete, and accurate, and revisions are made when necessary for calculating financial assistance; and all available data sources are utilized to identify ineligible providers and prevent them from receiving financial assistance.- Status
- Closed Implemented
- Responsible Agency
- HRSA
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 05/22/2024
- Legislative Related
- No
-
Medicare Advantage Compliance Audit of Diagnosis Codes That CarePlus Health Plans, Inc. (Contract H1019) Submitted to CMS
24-A-04-008.01We recommend that CarePlus Health Plans, Inc. refund to the Federal Government the $641,467 of net overpayments.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- $641,467
- Last Update Received
- 09/30/2025
- Next Update Expected
- 03/30/2026
- Legislative Related
- No
24-A-04-008.02We recommend that CarePlus Health Plans, Inc. ensure that its policies and procedures have been adequately designed and implemented to prevent, detect, and correct noncompliance with Federal requirements for diagnosis codes that are used to calculate risk-adjusted payments.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 09/30/2025
- Next Update Expected
- 03/30/2026
- Legislative Related
- No
-
New York City Department of Health and Mental Hygiene Charged Some Unallowable Costs to Its CDC COVID-19 Award
24-A-04-009.01We recommend that NYC DOHMH refund $15,671,958 to the Federal government.- Status
- Open Unimplemented
- Responsible Agency
- CDC
- Response
- Concur
- Potential Savings
- $15,671,958
- Last Update Received
- 09/30/2024
- Next Update Expected
- 04/03/2025
- Legislative Related
- No
24-A-04-009.02We recommend that NYC DOHMH strengthen its oversight of subrecipients to prevent future unallowable payments by reviewing subrecipient invoices and supporting documentation to ensure costs claimed are allowable and allocable.- Status
- Closed Implemented
- Responsible Agency
- CDC
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 10/03/2024
- Legislative Related
- No
-
CDC's Internal Control Weaknesses Led to Its Initial COVID-19 Test Kit Failure, but CDC Ultimately Created a Working Test Kit
24-A-04-007.01We recommend that the Centers for Disease Control and Prevention create policies and procedures for developing test kits that include roles, responsibilities, and oversight.- Status
- Closed Implemented
- Responsible Agency
- CDC
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 05/09/2024
- Legislative Related
- No
24-A-04-007.02We recommend that the Centers for Disease Control and Prevention ensure that the recently finalized GRF addresses the findings we identified in this report.- Status
- Closed Implemented
- Responsible Agency
- CDC
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 05/09/2024
- Legislative Related
- No
24-A-04-007.03We recommend that the Centers for Disease Control and Prevention develop and implement documented processes to ensure that adequate staffing and laboratory space can be obtained for future responses and provide for separation of duties and supervisor controls.- Status
- Closed Implemented
- Responsible Agency
- CDC
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 05/09/2024
- Legislative Related
- No
24-A-04-007.04We recommend that CDC re-evaluate the IMS structure at all levels of CDC's response framework and integrate positions or roles and responsibilities that provide effective oversight of a response effort, including a laboratory-based response effort.- Status
- Closed Implemented
- Responsible Agency
- CDC
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 05/09/2024
- Legislative Related
- No
24-A-04-007.05We recommend CDC implement a CDC-wide laboratory document control system.- Status
- Closed Implemented
- Responsible Agency
- CDC
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 01/17/2025
- Legislative Related
- No
24-A-04-007.06We recommend that CDC ensure that all infectious disease laboratories implement and periodically evaluate a QMS.- Status
- Closed Implemented
- Responsible Agency
- CDC
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 01/17/2025
- Legislative Related
- No
-
States Face Ongoing Challenges in Meeting Third-Party Liability Requirements for Ensuring That Medicaid Functions as the Payer of Last Resort
24-A-05-006.01We recommend that the Centers for Medicare & Medicaid Services use the information we obtained from States about the challenges they are still encountering and develop an action plan for helping States more easily identify liable third parties and recover Medicaid payments.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 02/11/2026
- Legislative Related
- No
24-A-05-006.02We recommend that the Centers for Medicare & Medicaid Services work with States, as appropriate, to encourage better cooperation from third parties that routinely resist States' TPL identification and recovery efforts.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 02/11/2026
- Next Update Expected
- 08/11/2026
- Legislative Related
- No
24-A-05-006.03We recommend that the Centers for Medicare & Medicaid Services, for the four States we identified as not having fully complied with the DRA's TPL provisions, verify whether the States have since come into compliance; and pursue corrective actions for States that have not fully complied.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 02/11/2026
- Next Update Expected
- 08/11/2026
- Legislative Related
- No
24-A-05-006.04We recommend that the Centers for Medicare & Medicaid Services verify whether Virginia has refunded the $1.25 million Federal share of the Medicaid TPL collections underreported during two fiscal quarters and, if not, require Virginia to refund any remaining amount owed.- Status
- Closed Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- $1,245,924
- Last Update Received
- -
- Closed Date
- 04/23/2025
- Legislative Related
- No
24-A-05-006.05We recommend that the Centers for Medicare & Medicaid Services provide guidance to States to assist them with developing processes that improve the reporting of Medicaid TPL amounts on the form 64.9A.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 04/22/2025
- Next Update Expected
- 10/23/2025
- Legislative Related
- No
24-A-05-006.06We recommend that the Centers for Medicare & Medicaid Services ensure that States have current instructions on completing the form 64.9A.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 04/22/2025
- Next Update Expected
- 10/23/2025
- Legislative Related
- No
24-A-05-006.07We recommend that the Centers for Medicare & Medicaid Services ensure that States correctly report TPL amounts on the form 64.9A.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 04/22/2025
- Next Update Expected
- 10/23/2025
- Legislative Related
- No
24-A-05-006.08We recommend that the Centers for Medicare & Medicaid Services remove or disable lines from the form 64.9A that States are supposed to leave blank.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 04/22/2025
- Next Update Expected
- 10/23/2025
- Legislative Related
- No
-
South Dakota MMIS and E&E System Security Controls Were Partially Effective and Improvements Are Needed
24-A-18-005.01We recommend that the South Dakota Department of Social Services remediate the six control findings OIG identified.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 09/24/2025
- Legislative Related
- No
-
Mississippi Did Not Always Invoice Rebates to Manufacturers for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations
24-A-07-004.01We recommend that the Mississippi Division of Medicaid work with CMS to calculate the rebate amount for claims identified in our findings, invoice drug manufacturers for the calculated rebates, and refund the Federal share of rebates collected for the years covered by our audit period and for years after our audit period.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- $13,707,201
- Last Update Received
- 04/03/2026
- Next Update Expected
- 10/13/2026
- Legislative Related
- No
24-A-07-004.02We recommend that the Mississippi Division of Medicaid strengthen internal controls to facilitate the invoicing of all physician-administered drugs for rebate.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 04/04/2025
- Legislative Related
- No
-
The Strategic National Stockpile Was Not Positioned To Respond Effectively to the COVID-19 Pandemic
24-A-04-003.01We recommend that ASPR mitigate the risk presented by relying on foreign supply chains and JIT inventory strategies when determining annual Stockpile purchases.- Status
- Closed Implemented
- Responsible Agency
- ASPR
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 07/12/2024
- Legislative Related
- No
24-A-04-003.02We recommend that ASPR develop a strategic plan for the Stockpile, that clearly defines the goals and objectives of the Stockpile, and the Stockpile's roles and responsibilities for responding to emergency events, including pandemics.- Status
- Closed Implemented
- Responsible Agency
- ASPR
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 01/17/2025
- Legislative Related
- No
24-A-04-003.03We recommend that ASPR work to increase the Stockpile's annual funding to keep pace with the Stockpile's increased responsibilities.- Status
- Closed Implemented
- Responsible Agency
- ASPR
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 07/12/2024
- Legislative Related
- Yes
24-A-04-003.04We recommend that ASPR reinstate the annual planning and review process and issue to Congress an updated PHEMCE SIP, PHEMCE Multiyear Budget, and Stockpile Annual Review Report.- Status
- Closed Implemented
- Responsible Agency
- ASPR
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 07/12/2024
- Legislative Related
- No
24-A-04-003.05We recommend that ASPR develop a plan and timeline for fully integrating the Stockpile within ASPR.- Status
- Closed Implemented
- Responsible Agency
- ASPR
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 07/12/2024
- Legislative Related
- No
24-A-04-003.06We recommend that ASPR develop a response plan, to include communication plans, for situations in which the Stockpile needs to respond to changes in roles and responsibilities during large-scale emergency responses.- Status
- Closed Implemented
- Responsible Agency
- ASPR
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 01/17/2025
- Legislative Related
- No
-
Medicare Could Save Millions if It Implements an Expanded Hospital Transfer Payment Policy for Discharges to Postacute Care
24-A-01-002.01We recommend that CMS conduct an analysis of its hospital transfer payment policy for discharges to PAC and expand the policy as necessary.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- $694,000,000
- Last Update Received
- 12/02/2025
- Next Update Expected
- 06/02/2026
- Legislative Related
- No
-
Medicare Advantage Compliance Audit of Specific Diagnosis Codes That Aetna, Inc. (Contract H5521) Submitted to CMS
24-A-01-001.01We recommend that Aetna, Inc. refund to the Federal Government the $632,070 of overpayments.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- $632,070
- Last Update Received
- 09/11/2025
- Next Update Expected
- 03/12/2026
- Legislative Related
- No
24-A-01-001.02We recommend that Aetna, Inc. determine, for the remaining 159 enrollee-years in the potentially mis-keyed diagnosis code high-risk group not reviewed as part of this audit, whether the medical records in each case support the diagnosis for the unrelated condition and refund any resulting overpayments to the Federal Government.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 09/11/2025
- Next Update Expected
- 03/12/2026
- Legislative Related
- No
24-A-01-001.03We recommend that Aetna, Inc. identify, for the high-risk diagnoses included in this report, similar instances of noncompliance that occurred before or after our audit period and refund any resulting overpayments to the Federal Government.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 09/11/2025
- Next Update Expected
- 03/12/2026
- Legislative Related
- No
24-A-01-001.04We recommend that Aetna, Inc. continue to examine its existing compliance procedures to identify areas where improvements can be made to ensure that diagnosis codes that are at high risk for being miscoded comply with Federal requirements (when submitted to CMS for use in CMS's risk adjustment program) and take the necessary steps to enhance those procedures.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 09/11/2025
- Next Update Expected
- 03/12/2026
- Legislative Related
- No
-
New Jersey Could Better Ensure That Nursing Homes Comply With Federal Requirements for Life Safety, Emergency Preparedness, and Infection Control
23-A-02-127.01We recommend that the New Jersey Department of Health follow up with the 20 nursing homes reviewed in this audit that demonstrated life safety, emergency preparedness, and infection control deficiencies to ensure that they have taken corrective actions.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 01/31/2024
- Legislative Related
- No
23-A-02-127.02We recommend that the New Jersey Department of Health instruct all nursing homes to install carbon monoxide detectors in accordance with New Jersey requirements.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 01/31/2024
- Legislative Related
- No
23-A-02-127.03We recommend that the New Jersey Department of Health work with CMS to develop a risk-based approach to identify nursing homes where surveys should be conducted more frequently than once every 15 months, such as those with a history of multiple high-risk deficiencies or frequent management turnover.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 01/31/2024
- Legislative Related
- No
23-A-02-127.04We recommend that the New Jersey Department of Health work with CMS to develop a plan to address the foundational issues preventing more frequent surveys at nursing homes with a history of multiple high-risk deficiencies.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 01/31/2024
- Legislative Related
- No
23-A-02-127.05We recommend that the New Jersey Department of Health work with CMS to develop standardized life safety training for nursing home staff.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 01/31/2024
- Legislative Related
- No
-
Biosimilars Have Lowered Costs for Medicare Part B and Enrollees, but Opportunities for Substantial Spending Reductions Still Exist
23-E-05-042.01CMS should pursue one or more payment changes that could further realize savings from biosimilars for Part B and enrollees.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Non-Concur
- Potential Savings
- -
- Last Update Received
- 06/23/2025
- Next Update Expected
- 06/25/2026
- Legislative Related
- No
-
District of Columbia Medicaid Fraud Control Unit: 2022 Onsite Review
22-E-06-041.01Develop policies and procedures to implement the District of Columbia OIG's expanded law enforcement authority and ensure that Unit investigators receive training on the new authorities.- Status
- Closed Implemented
- Responsible Agency
- MFCU
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 04/02/2025
- Legislative Related
- No
22-E-06-041.02Build upon its efforts with the District's Medicaid agency to increase fraud referrals from the MCOs.- Status
- Closed Implemented
- Responsible Agency
- MFCU
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 06/07/2024
- Legislative Related
- No
22-E-06-041.03Ensure that supervisory reviews of case files are conducted and documented in accordance with Unit policy.- Status
- Closed Implemented
- Responsible Agency
- MFCU
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 06/07/2024
- Legislative Related
- No
22-E-06-041.04Ensure that all convictions and adverse actions are reported to Federal partners within the appropriate timeframes.- Status
- Closed Implemented
- Responsible Agency
- MFCU
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 06/07/2024
- Legislative Related
- No
-
Many Medicaid Enrollees with Opioid Use Disorder Were Treated with Medication; However, Disparities Present Concerns
23-E-BL-041.01CMS should encourage and support States' efforts to reduce barriers to medications for opioid use disorder (MOUD), especially among groups who may be underserved.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 03/11/2025
- Next Update Expected
- 03/17/2026
- Legislative Related
- No
23-E-BL-041.02CMS should encourage States and work with Federal partners to educate Medicaid and CHIP enrollees about access to medications for opioid use disorder (MOUD).- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 03/11/2025
- Next Update Expected
- 03/17/2026
- Legislative Related
- No
-
Home Health Agencies Rarely Furnished Services Via Telehealth Early in the COVID-19 Public Health Emergency
23-A-05-124.01We recommend that CMS monitor HHA reporting of the new G-codes to determine whether further updates to regulations or guidance are necessary.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 02/13/2025
- Next Update Expected
- 08/14/2025
- Legislative Related
- No
-
Four States Reviewed Received Increased Medicaid COVID-19 Funding Even Though They Terminated Some Enrollees' Coverage for Unallowable or Potentially Unallowable Reasons
23-A-06-120.01We recommend that the Centers for Medicare & Medicaid Services work with the four States to determine what amount, if any, of the funding they received because of the increased COVID-19 FMAP should be refunded to the Federal Government.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 04/29/2025
- Next Update Expected
- 11/02/2025
- Legislative Related
- No
23-A-06-120.02We recommend that the Centers for Medicare & Medicaid Services work with Minnesota to determine whether Medicaid enrollees were responsible for any cost-sharing for COVID-19 testing, services, or treatments and, if any cost-sharing is identified, work with Minnesota to ensure that enrollees are reimbursed for any out-of-pocket expenses incurred.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 04/29/2025
- Next Update Expected
- 11/02/2025
- Legislative Related
- No
-
Medicare Advantage Compliance Audit of Diagnosis Codes That Health Net of California, Inc. (Contract H0562) Submitted to CMS
23-A-09-121.01We recommend that Health Net of California, Inc. refund to the Federal Government the $69,182 of net overpayments.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- $69,182
- Last Update Received
- 03/21/2024
- Next Update Expected
- 03/17/2026
- Legislative Related
- No
23-A-09-121.02We recommend that Health Net of California, Inc. continue to improve its policies and procedures to prevent, detect, and correct noncompliance with Federal requirements for diagnosis codes that are used to calculate risk-adjusted payments.- Status
- Open Unimplemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- 03/21/2024
- Next Update Expected
- 03/17/2026
- Legislative Related
- No
-
Alabama Did Not Always Invoice Rebates to Manufacturers for Pharmacy and Physician-Administered Drugs
23-A-04-118.01We recommend that the Alabama Medicaid Agency refund to the Federal Government $14,960,673 (Federal share) for claims for single-source physician-administered drugs that were ineligible for Federal reimbursement.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- $14,960,673
- Last Update Received
- -
- Closed Date
- 10/08/2025
- Legislative Related
- No
23-A-04-118.02We recommend that the Alabama Medicaid Agency refund to the Federal Government $43,981 (Federal share) for claims for top-20 multiple-source physician-administered drugs that were ineligible for Federal reimbursement.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- $43,981
- Last Update Received
- -
- Closed Date
- 10/08/2025
- Legislative Related
- No
23-A-04-118.03We recommend that the Alabama Medicaid Agency work with CMS to determine and refund the unallowable portion of $290,455 (Federal share) for other claims for multiple-source physician-administered drugs that may have been ineligible for Federal reimbursement and consider invoicing drug manufacturers for rebates for those drug claims that CMS determines are allowable.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- $290,455
- Last Update Received
- -
- Closed Date
- 10/08/2025
- Legislative Related
- No
23-A-04-118.04We recommend that the Alabama Medicaid Agency complete the process for rebating pharmacy drugs totaling $6,568 ($4,719 Federal share) for single-source and $219,220 ($157,395 Federal share) for multiple-source drugs that it had not previously collected a rebate on or refund the Federal share.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- $162,114
- Last Update Received
- -
- Closed Date
- 10/08/2025
- Legislative Related
- No
23-A-04-118.05We recommend that the Alabama Medicaid Agency work with CMS to determine and refund the unallowable portion of Federal reimbursement for physician-administered drugs that were not invoiced for rebates after December 31, 2019.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 10/08/2025
- Legislative Related
- No
23-A-04-118.06We recommend that the Alabama Medicaid Agency strengthen its internal controls to ensure that all pharmacy and physician-administered drugs eligible for rebates are invoiced.- Status
- Closed Implemented
- Responsible Agency
- CMS
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 10/08/2025
- Legislative Related
- No
-
FDA Could Take Stronger Enforcement Action Against Tobacco Retailers With Histories of Sales to Youth and Other Violations
23-E-01-040.01FDA should give greater weight to retailers' past noncompliance when taking enforcement actions against retailers with histories of violations.- Status
- Closed Implemented
- Responsible Agency
- FDA
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 03/31/2025
- Legislative Related
- No
23-E-01-040.02FDA should determine whether variation in inspection activity on the basis of neighborhoods' socioeconomic status is appropriate and the extent to which it is meeting FDA's objective for protecting vulnerable populations.- Status
- Closed Implemented
- Responsible Agency
- FDA
- Response
- Concur
- Potential Savings
- -
- Last Update Received
- -
- Closed Date
- 03/31/2025
- Legislative Related
- No